XPO1 and primary cutaneous T-cell non-Hodgkin lymphoma: We describe the mechanisms of XPO1 inhibitor-mediated inhibition of proliferation and induction of apoptosis in CTCL cell lines and the in vivo antitumor efficacy of KPT-330 in a murine xenograft model of CTCL.